Psychiatrists, GPs and other professionals working in the substance misuse field will benefit from reading these new guidelines from the British Association for Psychopharmacology. The guidelines cover the pharmacological management of alcohol, nicotine, opioids, benzodiazepines, stimulants and associated comorbidity with mental health problems and substance use or abuse in pregnancy. They look specifically at comorbidity, [read the full story…]
End of life care is an emotive subject and perhaps none more so than in people with dementia where it can be particularly difficult to ensure that individuals get the care they want in the final months of their life. Both the Department of Health and NICE have published guidance in this area and this [read the full story…]
The NHS Information Centre have published their annual series of reports about alcohol use and misuse. The reports cover a range of issues including drinking habits and behaviours among adults (aged 16 and over) and school children (aged 11 to 15), drinking-related ill health and mortality, affordability of alcohol, alcohol related admissions to hospital and alcohol-related [read the full story…]
Fish oil supplements are big business. The worldwide omega-3 market has recently been valued at around $5 billion with 40% growth predicted between 2010 and 2015. Omega-3 fatty acids are fats responsible for many important jobs in the body. We get these fats through our daily diets and the three major omega-3 fats are: Alpha [read the full story…]
The newer second-generation antipsychotic drugs (Risperidone, Quetiapine, Amisulpride, Aripiprazole, Clozapine, Olanzapine) are promoted because they have a lower risk of extrapyramidal side effects than older drugs. Drug companies often promote these newer drugs as virtually free from extrapyramidal side effects, but the patients who take them and the clinicians who prescribe them often don’t agree. [read the full story…]
Ooh, what a palaver over the depression and exercise story! Such a lot of words have been written about the study published in the BMJ last week, including by me. The study itself was well conducted but frankly disappointing (for us readers and the researchers themselves), finding as it did that a specific treatment to [read the full story…]
In 1998 a very small study was published, involving just 3 children with autism, who were treated with a hormone called secretin that controls digestion. Here’s the abstract of the study by Horvath et al: We report three children with autistic spectrum disorders who underwent upper gastrointestinal endoscopy and intravenous administration of secretin to stimulate [read the full story…]
Back from my 5-mile run around the woodland yesterday morning I sat down to catch up on the latest elf stories. Many of the national newspapers reported on a new randomised controlled trial published in the BMJ, which studied ‘facilitated physical activity’ for people with depression. The headlines seemed to be in agreement: Exercise ‘no [read the full story…]
Preterm babies are three times more likely to be admitted to hospital for a mental health problem as an adult than normal term babies, according to a study published in the Archives of General Psychiatry by researchers in the UK and Sweden. About 1 in every 13 children born in the UK are classified as [read the full story…]
Commissioners, health professionals and social care professionals will all be interested in the new Long Term Conditions Compendium of Information published by the Department of Health. This third edition updates the version produced in 2008 and provides the evidence for improving care and outcomes for people with long-term conditions. 70% of the total health and [read the full story…]
